TRANXENE CAP 7.5MG
TRANXENE CAP 7.5MG
Discontinued
DIN Number
00264946
Drug Class
Human
Market Date
Dec 31, 1976
Company
HC
ABBOTT LABORATORIES, LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number00264946
AIG Number0108895002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05BA05 CLORAZEPATE POTASSIUM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
CLORAZEPATE DIPOTASSIUMActive
Strength: 7.5 MG / CAP
Monograph: CLORAZEPATE DIPOTASSIUM